These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29081434)

  • 41. Governmental oversight of prescribing medications: history of the US Food and Drug Administration and prescriptive authority.
    Plank LS
    J Midwifery Womens Health; 2011; 56(3):198-204. PubMed ID: 21535368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug use and drug policy in Hong Kong: changing patterns and new challenges.
    Cheung YW; Ch'ien JM
    Subst Use Misuse; 1996; 31(11-12):1573-97. PubMed ID: 9026362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug legalization, harm reduction, and drug policy.
    DuPont RL; Voth EA
    Ann Intern Med; 1995 Sep; 123(6):461-5. PubMed ID: 7639447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Johnny's in the basement, mixin' up the medicine. Review of Angell, Avorn, and Daemmrich on the modern pharmaceutical predicament.
    Mirowski P
    Soc Stud Sci; 2007 Apr; 37(2):311-27. PubMed ID: 17645149
    [No Abstract]   [Full Text] [Related]  

  • 46. James Harvey Young and medical education.
    Turton FE
    Pharos Alpha Omega Alpha Honor Med Soc; 2009; ():58. PubMed ID: 19263656
    [No Abstract]   [Full Text] [Related]  

  • 47. The relevancy of drug control in the United States during the seventies.
    Ingersoll JE
    J Forensic Sci; 1972 Jan; 17(1):3-14. PubMed ID: 4618278
    [No Abstract]   [Full Text] [Related]  

  • 48. Rethinking 'flexibilities' in the international drug control system-Potential, precedents and models for reforms.
    Collins J
    Int J Drug Policy; 2018 Oct; 60():107-114. PubMed ID: 28129946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chasing the dragon: the cultural metamorphosis of opium in the United States, 1825-1935.
    Aurin M
    Med Anthropol Q; 2000 Sep; 14(3):414-41. PubMed ID: 11036586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cocaine: from medical marvel to modern menace in the United States, 1884-1920. [Review of: Spillaine, J. F. Cocaine: from medical marvel to modern menace in the United States, 1884-1920. Baltimore: Johns Hopkins U. Pr., 2000].
    Burnham JC
    J Soc Hist; 2001; 35(2):507-9. PubMed ID: 17078202
    [No Abstract]   [Full Text] [Related]  

  • 51. Cocaine: from medical marvel to modern menace in the United States, 1884-1920. [Review of: Spillaine, J. F. Cocaine: from medical marvel to modern menace in the United States, 1884-1920. Baltimore: Johns Hopkins U. Pr., 2000].
    Himmelstein JL
    Am Hist Rev; 2001; 106(5):1818-9. PubMed ID: 17078201
    [No Abstract]   [Full Text] [Related]  

  • 52. Physician-statesmen.
    Schwartz RA; Adler KP
    Pharos Alpha Omega Alpha Honor Med Soc; 2009; ():57-8. PubMed ID: 19266643
    [No Abstract]   [Full Text] [Related]  

  • 53. An alternative perspective: homeopathic drugs, Royal Copeland, and federal drug regulation.
    Junod SW
    Food Drug Law J; 2000; 55(1):161-83. PubMed ID: 12375600
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug policy and Collective Health: necessary dialogues.
    Gomes-Medeiros D; Faria PH; Campos GWS; Tófoli LF
    Cad Saude Publica; 2019 Jul; 35(7):e00242618. PubMed ID: 31365702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The FDA's regulation and control of antibiotics in the 1950s: the Henry Welch scandal, Félix Martí-Ibáñez, and Charles Pfizer & Co.
    McFadyen RE
    Bull Hist Med; 1979; 53(2):159-69. PubMed ID: 389316
    [No Abstract]   [Full Text] [Related]  

  • 56. James Harvey Young, PhD, (1915-2006). Historian of medical quackery.
    Marcus DM
    Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(3):16-21. PubMed ID: 18767597
    [No Abstract]   [Full Text] [Related]  

  • 57. Shattuck lecture. Innovation, regulation, and the FDA.
    Hamburg MA
    N Engl J Med; 2010 Dec; 363(23):2228-32. PubMed ID: 21121835
    [No Abstract]   [Full Text] [Related]  

  • 58. The rise, fall, and revival of recovery in drug policy.
    Berridge V
    Lancet; 2012 Jan; 379(9810):22-3. PubMed ID: 22232800
    [No Abstract]   [Full Text] [Related]  

  • 59. Senator Royal Copeland. The medical and political career of a homeopathic physician.
    Davidson JR; Dantas F
    Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(3):4-10. PubMed ID: 18767595
    [No Abstract]   [Full Text] [Related]  

  • 60. Tobacco, public health, and the FDA.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2009 Jul; 361(4):402-3. PubMed ID: 19546344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.